Vir Biotechnology, Inc. logo

VIRVir Biotechnology, Inc.

VIR Stock Price, Valuation & Chart | Vir Biotechnology, Inc.

Compare
$8.390-0.48 (-5.41%)

At close · 20 Nov 2026, 09:00 pm

VIR Historical price chart

VIR Key Stats

Fair value estimate
Disclaimer

General advice only. Model estimate, not a price target or a recommendation to buy, sell or hold. Not based on your objectives, financial situation or needs: consider the product disclosure statement and your own circumstances. Alphacentric Technology Pty Ltd t/a Tickerplace is a CAR (No. 001324046) of MF & Co. Asset Management Pty Ltd (AFSL 520442).

Market Capitalization1.44B
PE Ratio-4.51
EPS-1.86
Trading Volume3.08M
Today's High/Low8.91/8.35
Dividend Yield0.00
52 Week High/Low14.38/5.45
Shares Outstanding171.27M

Price and calculated levels

A preview of the VIR chart Pro members see. Dollar amounts stay locked. Each line is a calculated margin of safety or premium price, not a forecast.

Price $•••$•••+100%$•••+90%$•••+80%$•••+60%$•••+40%$•••+20%$•••Fair value$•••−20%$•••−30%$•••−40%$•••−50%$•••−60%
VIR Financial Statement
VIR Analyst ratings
VIR Analysis & performance metrics

VIR Company profile

Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab…

VIR Management team

Management
Mark D. Eisner M.D., M.P.H.
Executive Vice President & Chief Medical Officer
Jason O'Byrne M.B.A.CFO
Executive Vice President & Chief Financial Officer
Vanina de Verneuil J.D.
Executive Vice President, General Counsel & Corporate Secretary
Louis J. Picker M.D.
Co-Founder & Scientific Advisor
Marianne De Backer M.B.A., M.Sc., Ph.D.CEO
Chief Executive Officer & Director
Maninder Hora Ph.D.
Executive Vice President & Chief Technical Operations Officer
Toby Medaris
Senior Vice President of Human Resources
Lawrence Corey M.D.
Co-Founder & Scientific Advisor
Total 8 executives

VIR Frequently asked questions

What is Vir Biotechnology, Inc. (VIR) Stock Price?

Current stock price of Vir Biotechnology, Inc. (VIR) stock is $8.390. The stock price is -5.41% lower in the session. The intraday range can be seen from this page. Volume of Vir Biotechnology, Inc. (VIR) stock is 3.08M.

Last updated at 20 Nov 2026, 09:00 pm.

Why is the Vir Biotechnology, Inc. (VIR) stock price going up or down today?

The stock price of Vir Biotechnology, Inc. (VIR) can change with earnings, company news, and overall market sentiment. Vir Biotechnology, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Vir Biotechnology, Inc. stock expensive at its current price?

Whether Vir Biotechnology, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for VIR on this page is -4.51. EPS on this page is -1.86. Compare those figures with peers and growth expectations before deciding if the current Vir Biotechnology, Inc. price is justified.

How has the stock price of Vir Biotechnology, Inc. (VIR) performed historically?

Historical performance for Vir Biotechnology, Inc. (VIR) is shown on the price chart on this page. Review multi-period moves alongside volume to see how VIR reacted to past earnings and market events.

Should I buy Vir Biotechnology, Inc. (VIR) stock, at this price?

Buying Vir Biotechnology, Inc. (VIR) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.